Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-08-08
2006-08-08
Chan, Christina (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S346000, C435S810000, C530S387900, C530S388100
Reexamination Certificate
active
07087391
ABSTRACT:
A hybridoma is selected that produces a monoclonal antibody exhibiting high reactivity to soluble hepatocyte growth factor activator inhibitor-1 (soluble HAI-1), the target monoclonal antibody is prepared from culture supernatant of the obtained hybridoma, and by using the antibody soluble HAI-1 is measured.
REFERENCES:
patent: 4281061 (1981-07-01), Zuk et al.
patent: 6225081 (2001-05-01), Shimomura et al.
patent: 0 759 467 (1997-02-01), None
patent: 11-035480 (1999-02-01), None
patent: 11-295309 (1999-10-01), None
patent: WO 01/68707 (2001-09-01), None
Goldsby et al., Immunology, Fifth edition, 2000, pp. 137-139.
Hiroaki Kataoka et al., “Hepatocyte Growth Factor Activator Inhibitor Type 1 is a Specific Cell Surface Binding Protein of Hepatocyte Growth Factor Activator (HGFA) and Regulates HGFA Activity in the Pericellular Microenvironment”, The Journal of Biological Chemistry, vol. 275, No. 51, pp. 40453-40462, Dec. 22, 2000.
Hiroaki Kataoka et al., “Distribution of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) in Human Tissues: Cellular Surface Localization of HAI-1 in Simple Columnar Epithelium and its Modulated Expression in Injured and Regenerative Tissues”, The Journal of Histochemistry & Cytochemistry, vol. 47, No. 5, pp. 673-682, May 1999.
Takeshi Shimomura et al., “Multiple Sites of Proteolytic Cleavage to Release Soluble Forms of Hepatocyte Growth Factor Activator Inhibitor Type 1 from a Transmembrane Form”, Journal of Biochemistry, vol. 126, No. 5, pp. 821-828, Nov. 1999.
Chen-Yong Lin et al., “Purification and Characterization of a Complex Containing Matriptase and a Kunitz-Type Serine Protease Inhibitor from Human Milk”, The Journal of Biological Chemistry, vol. 274, No. 26, Jun. 25, 1999, pp. 18237-18242.
Hiroshi Itoh et al., “Upregulation of HGF Activator Inhibitor Type 1 But Not Type 2 Along with Regeneration of Intestinal Mucosa”, Am. J. Physiol. Gastrointest. Liver Physiol. vol. 278, pp. G635-G643, 2000.
Hiroshi Itoh et al., “Genomic Structure and Chromosomal Localization of the Human Hepatocyte Growth Factor Activator Inhibitor Type 1 and 2 Genes”, Eur. J. Biochem., vol. 267, pp. 3351-3359, FEBS 2000.
Hiroaki Kataoka et al., “Activation of Hepatocyte Growth Factor/Scatter Factor in Colorectal Carcinoma”, Cancer Research, vol. 60, pp. 6148-6159, Nov. 1, 2000.
Michael Oberst et al., “Matriptase and HAI-1 are Expressed by Normal and Malignant Epithelial Cellsin vitroandin vivo”, American Journal of Pathology, vol. 158, No. 4, pp. 1301-1311, Apr. 2001.
Nagaike Kazuhiro
Naka Daiji
Yamagishi Toshiya
Belyavskyi Michail
Chan Christina
Mitsubishi Chemical Corporation
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Antibody to hepatocyte growth factor activator inhibitor-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody to hepatocyte growth factor activator inhibitor-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody to hepatocyte growth factor activator inhibitor-1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3662294